U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07637487) titled 'Tocotrienol Supplementa as A Senolytic Agent in Middle-aged Adults' on Dec. 29, 2025.
Brief Summary: The goal of this clinical trial is to determine whether tocotrienol works as a senolytic agent to delay age-related biological changes in middle-aged adults. The study will also evaluate the safety of tocotrienol supplementation. The main questions it aims to answer are:
Does tocotrienol reduce markers of cellular senescence, inflammation, oxidative stress, and mitochondrial dysfunction?
What health changes or medical issues occur in participants taking tocotrienol?
Researchers will compare tocotrienol-rich fraction to a placebo (...